<- Go Home
ImmuCell Corporation
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.
Market Cap
$28.4M
Volume
11.8K
Cash and Equivalents
$1.3M
EBITDA
-$633.7K
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$6.6M
Profit Margin
28.32%
52 Week High
$5.64
52 Week Low
$3.34
Dividend
N/A
Price / Book Value
1.21
Price / Earnings
-6.94
Price / Tangible Book Value
1.22
Enterprise Value
$42.9M
Enterprise Value / EBITDA
-254.18
Operating Income
-$3.3M
Return on Equity
-16.10%
Return on Assets
-4.87
Cash and Short Term Investments
$1.3M
Debt
$15.8M
Equity
$23.5M
Revenue
$23.2M
Unlevered FCF
$848.4K
Sector
Biotechnology
Category
N/A